Key result
Intracerebroventricular infusion of losartan significantly reduced elevated cardiac sympathetic nerve activity (from 88±3 to 69±5 bursts per 100 heart beats) in an ovine model of heart failure.
Why the study?
Does central intracerebroventricular infusion of losartan reduce cardiac sympathetic nerve activity in an ovine model of heart failure?
Does central intracerebroventricular infusion of losartan reduce cardiac sympathetic nerve activity in an ovine model of heart failure?
Central angiotensin type 1 receptor blockade with losartan reduces elevated cardiac sympathetic nerve activity in an ovine model of heart failure, indicating a critical role for central angiotensin receptors.
Answers are grounded in this paper and cite their sources.
No immediate clinical implications; extends preclinical evidence for central AT1 blockade in ovine HF.
In heart failure (HF), cardiac sympathetic nerve activity (SNA; CSNA) is increased, which has detrimental effects on the heart and promotes arrhythmias and sudden death. There is evidence that the central renin-angiotensin system plays an important role in stimulating renal SNA in HF. Because SNA to individual organs is differentially controlled, we have investigated whether central angiotensin receptor blockade decreases CSNA in HF. We simultaneously recorded CSNA and renal SNA in conscious normal sheep and in sheep with HF induced by rapid ventricular pacing (ejection fraction: <40%). The effect of blockade of central angiotensin type 1 receptors by intracerebroventricular infusion of losartan (1 mg/h for 5 hours) on resting levels and baroreflex control of CSNA and renal SNA were determined. In addition, the levels of angiotensin receptors in central autonomic nuclei were determined using autoradiography. Sheep in HF had a large increase in CSNA (43±2 to 88±3 bursts per 100 heart beats; P<0.05) and heart rate, with no effect on renal SNA. In HF, central infusion of losartan for 5 hours significantly reduced the baseline levels of CSNA (to 69±5 bursts per 100 heart beats) and heart rate. Losartan had no effect in normal animals. In HF, angiotensin receptor levels were increased in the paraventricular nucleus and supraoptic nucleus but reduced in the area postrema and nucleus tractus solitarius. In summary, infusion of losartan reduced the elevated levels of CNSA in an ovine model of HF, indicating that central angiotensin receptors play a critical role in stimulating the increased sympathetic activity to the heart.
No takes yet. Share an insight, caveat, or question.
Ramchandra et al. (2012) studied Heart failure. Intracerebroventricular infusion of losartan vs. Normal animals / baseline was evaluated on Cardiac sympathetic nerve activity (CSNA). Intracerebroventricular infusion of losartan significantly reduced elevated cardiac sympathetic nerve activity (from 88±3 to 69±5 bursts per 100 heart beats) in an ovine model of heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: